Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Sep;58(1):89–100. doi: 10.1111/j.1476-5381.1976.tb07696.x

The release of a coronary vasodilator metabolite from the guinea-pig isolated perfused heart stimulated by catecholamines, histamine and electrical pacing and by exposure to anoxia.

K J Broadley
PMCID: PMC1667132  PMID: 974380

Abstract

1 A procedure involving two guinea-pig isolated hearts perfused in series is described for detecting in the recipient heart the release of a possible coronary vasodilator metabolite from the donor heart. 2 Adrenaline and isoprenaline stimulated the rate and force of contraction and produced a multiphasic coronary vascular response, the predominant phase of which was vasodilatation. When the beta-adrenoceptors of the recipient heart were blocked, stimulation of the donor heart by the catecholamines was associated with a coronary vasodilatation of the recipient heart. 3 Histamine stimulated rate and force of contraction and was predominantly coronary vasodilator. After blockade of histamine H1- and H2-receptors in the recipient heart, coronary vasodilatation followed increases in activity of the donor heart in response to histamine. 4 These vasodilator responses of the recipient heart were attributed to the release from the donor heart of a vasodilator metabolite by the increased activity. This is the proposed mechanism for the predominant coronary vasodilator response to catecholamines and histamine. 5 Periods of electrically-paced tachycardia and anoxia of the donor heart also led to the release of vasodilator activity. 6 The possible identity of the metabolite is discussed.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam K. R., Boyles S., Scholfield P. C. Cardio-selective beta-adrenoceptor blockade and the coronary circulation. Br J Pharmacol. 1970 Nov;40(3):534–536. doi: 10.1111/j.1476-5381.1970.tb10639.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anrep G. V., Häusler H. The coronary circulation: II. The effect of changes of temperature and of heart rate. J Physiol. 1929 Jun 7;67(3):299–314. doi: 10.1113/jphysiol.1929.sp002571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BERNE R. M. Effect of epinephrine and norepinephrine on coronary circulation. Circ Res. 1958 Sep;6(5):644–655. doi: 10.1161/01.res.6.5.644. [DOI] [PubMed] [Google Scholar]
  4. BERNE R. M. REGULATION OF CORONARY BLOOD FLOW. Physiol Rev. 1964 Jan;44:1–29. doi: 10.1152/physrev.1964.44.1.1. [DOI] [PubMed] [Google Scholar]
  5. Bayer B. L., Mentz P., Förster W. Uber spezifische Unterschiede zwischen den adrenergen -Rezeptoren an Herz und Koronarien. Arch Int Pharmacodyn Ther. 1972 Dec;200(2):341–347. [PubMed] [Google Scholar]
  6. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  7. Block A. J., Feinberg H., Herbaczynska-Cedro K., Vane J. R. Anoxia-induced release of prostaglandins in rabbit isolated hearts. Circ Res. 1975 Jan;36(1):34–35. doi: 10.1161/01.res.36.1.34. [DOI] [PubMed] [Google Scholar]
  8. Broadley K. J. An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation. Br J Pharmacol. 1970 Dec;40(4):617–629. doi: 10.1111/j.1476-5381.1970.tb10642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Broadley K. J. Proceedings: A procedure to demonstrate the release of a vasoactive metabolite by catecholamines from perfused guinea-pig hearts. Br J Pharmacol. 1975 Jun;54(2):223P–224P. [PMC free article] [PubMed] [Google Scholar]
  10. Broadley K. J. The role of H1 and H2-receptors in the coronary vascular response to histamine of isolated perfused hearts of guinea-pigs and rabbits. Br J Pharmacol. 1975 Aug;54(4):511–521. doi: 10.1111/j.1476-5381.1975.tb07599.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. CORDAY E., GOLD H., DE VERA L. B., WILLIAMS J. H., FIELDS J. Effect of the cardiac arrhythmias on the coronary circulation. Ann Intern Med. 1959 Mar;50(3):535–553. doi: 10.7326/0003-4819-50-3-535. [DOI] [PubMed] [Google Scholar]
  12. DOUGLAS R. C., ARMENGOL V., TALESNIK J. Influence of cardiac activity on coronary flow control. Acta Physiol Lat Am. 1960;10:205–216. [PubMed] [Google Scholar]
  13. DRISCOL T. E., BERNE R. M. Role of potassium in regulation of coronary blood flow. Proc Soc Exp Biol Med. 1957 Nov;96(2):505–508. doi: 10.3181/00379727-96-23521. [DOI] [PubMed] [Google Scholar]
  14. Dempsey P. J., Cooper T. Pharmacology of the coronary circulation. Annu Rev Pharmacol. 1972;12:99–110. doi: 10.1146/annurev.pa.12.040172.000531. [DOI] [PubMed] [Google Scholar]
  15. Drew G. M., Levy G. P. Characterization of the coronary vascular -adrenoceptor in the pig. Br J Pharmacol. 1972 Oct;46(2):348–350. doi: 10.1111/j.1476-5381.1972.tb06880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Drury A. N., Szent-Györgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol. 1929 Nov 25;68(3):213–237. doi: 10.1113/jphysiol.1929.sp002608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ercan Z. S., Bökesoy T. A., Türker R. K. A study of the histamine H2-receptors in heart muscle and coronary vessels. Eur J Pharmacol. 1974 Jul;27(2):259–262. doi: 10.1016/0014-2999(74)90156-3. [DOI] [PubMed] [Google Scholar]
  18. GARCIA RAMOS J., ALANIS J., LUCO J. Estudios sobre la circulación coronaria. II. Las acciones del vago y del simpático. Arch Inst Cardiol Mex. 1950 Aug 31;20(4):534–550. [PubMed] [Google Scholar]
  19. HARDIN R. A., SCOTT J. B., HADDY F. J. Effect of epinephrine and norepinephrine on coronary vascular resistance in dogs. Am J Physiol. 1961 Aug;201:276–280. doi: 10.1152/ajplegacy.1961.201.2.276. [DOI] [PubMed] [Google Scholar]
  20. HASHIMOTO K., SHIGEI T., IMAI S., SAITO Y., YAGO N., UEI I., CLARK R. E. Oxygen consumption and coronary vascular tone in the isolated fibrillating dog heart. Am J Physiol. 1960 May;198:965–970. doi: 10.1152/ajplegacy.1960.198.5.965. [DOI] [PubMed] [Google Scholar]
  21. Haddy F. J., Scott J. B. Metabolically linked vasoactive chemicals in local regulation of blood flow. Physiol Rev. 1968 Oct;48(4):688–707. doi: 10.1152/physrev.1968.48.4.688. [DOI] [PubMed] [Google Scholar]
  22. KLARWEIN M., KAKO K., CHRYSOHOU A., BING R. J. Effect of atrial and ventricular fibrillation and ventricular tachycardia on carbohydrate metabolism of the heart. Circ Res. 1961 Jul;9:819–825. doi: 10.1161/01.res.9.4.819. [DOI] [PubMed] [Google Scholar]
  23. Katori M., Berne R. M. Release of adenosine from anoxic hearts. Relationship to coronary flow. Circ Res. 1966 Aug;19(2):420–425. doi: 10.1161/01.res.19.2.420. [DOI] [PubMed] [Google Scholar]
  24. Krebs R., Schror K. Actions of prostaglandin E2 on myocardial mechanics, coronary vascular resistance and oxygen consumption in the guinea-pig isolated heat preparation. Br J Pharmacol. 1975 Nov;55(3):403–408. doi: 10.1111/j.1476-5381.1975.tb06944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Levi R., Capurro N., Lee C. H. Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-and H2-receptor agonists and antagonists. Eur J Pharmacol. 1975 Feb;30(2):328–335. doi: 10.1016/0014-2999(75)90117-x. [DOI] [PubMed] [Google Scholar]
  26. Levi R., Kuye J. O. Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-receptor antagonists. Eur J Pharmacol. 1974 Aug;27(3):330–338. doi: 10.1016/0014-2999(74)90008-9. [DOI] [PubMed] [Google Scholar]
  27. Lochner W., Parratt J. R. A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism. Br J Pharmacol Chemother. 1966 Jan;26(1):17–26. doi: 10.1111/j.1476-5381.1966.tb01806.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lucchesi B. R., Hodgeman R. J. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation. J Pharmacol Exp Ther. 1971 Jan;176(1):200–211. [PubMed] [Google Scholar]
  29. MELVILLE K. I., LU F. C. Effect of epinephrine, aminophylline, nitroglycerine and papaverine on coronary inflow and on heart contraction, as recorded concurrently. J Pharmacol Exp Ther. 1950 Jul;99(3):286–303. [PubMed] [Google Scholar]
  30. MOHME-LUNDHOLM E. Mechanism of the relaxing effect of adrenaline on bovine coronary vessels. Acta Physiol Scand. 1957 Mar 7;38(3-4):255–264. doi: 10.1111/j.1748-1716.1957.tb01388.x. [DOI] [PubMed] [Google Scholar]
  31. Mark A. L., Abboud F. M., Schmid P. G., Heistad D. D., Mayer H. E. Differences in direct effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels. J Clin Invest. 1972 Feb;51(2):279–287. doi: 10.1172/JCI106812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. McNeill J. H., Verma S. C. Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate. J Pharmacol Exp Ther. 1974 Jan;188(1):180–188. [PubMed] [Google Scholar]
  33. Parratt J. R. Adrenergic receptors in the coronary circulation. Am Heart J. 1967 Jan;73(1):137–140. doi: 10.1016/0002-8703(67)90321-3. [DOI] [PubMed] [Google Scholar]
  34. Parratt J. R. Pharmacological aspects of the coronary circulation. Prog Med Chem. 1969;6:11–66. doi: 10.1016/s0079-6468(08)70196-6. [DOI] [PubMed] [Google Scholar]
  35. Parratt J. R., Wadsworth R. M. The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation. Br J Pharmacol. 1970 Jun;39(2):296–308. doi: 10.1111/j.1476-5381.1970.tb12893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Parratt J. R., Wadsworth R. M. The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine. Br J Pharmacol. 1972 Dec;46(4):585–593. doi: 10.1111/j.1476-5381.1972.tb06885.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Reinhardt D., Wagner J., Schümann H. J. Differentiation of H1- and H2-receptors mediating positive chrono- and inotropic responses to histamine on atrial preparations of the guinea-pig. Agents Actions. 1974 Oct;4(4):217–221. doi: 10.1007/BF01965222. [DOI] [PubMed] [Google Scholar]
  38. Ross G., Jorgensen C. R. Effects of a cardio-selective beta-adrenergic blocking agent on the heart and coronary circulation. Cardiovasc Res. 1970 Apr;4(2):148–153. doi: 10.1093/cvr/4.2.148. [DOI] [PubMed] [Google Scholar]
  39. Ross G. Myocardial and coronary vascular effects of salbutamol. Cardiovasc Res. 1974 Jan;8(1):1–7. doi: 10.1093/cvr/8.1.1. [DOI] [PubMed] [Google Scholar]
  40. SIEGEL J. H., GILMORE J. P., SARNOFF S. J. Myocardial extraction and production of catechol amines. Circ Res. 1961 Nov;9:1336–1350. doi: 10.1161/01.res.9.6.1336. [DOI] [PubMed] [Google Scholar]
  41. Steinburg M. I., Holland D. R. Separate receptors mediating the positive inotropic and chronotropic effect of histamine in guinea-pig atria. Eur J Pharmacol. 1975 Nov;34(1):95–104. doi: 10.1016/0014-2999(75)90229-0. [DOI] [PubMed] [Google Scholar]
  42. Talesnik J., Sunahara F. A. Enhancement of metabolic coronary dilatation by aspirin-like substances by suppression of prostaglandin feedback control? Nature. 1973 Aug 10;244(5415):351–353. doi: 10.1038/244351a0. [DOI] [PubMed] [Google Scholar]
  43. WEGRIA R. Pharmacology of the coronary circulation. Pharmacol Rev. 1951 Jun;3(2):197–246. [PubMed] [Google Scholar]
  44. Wennmalm A., Pham-Huu-Chanh, Junstad S. Hypoxia causes prostaglandin release from perfused rabbit hearts. Acta Physiol Scand. 1974 May;91(1):133–135. doi: 10.1111/j.1748-1716.1974.tb05666.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES